Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether bexarotene is effective in preventing breast cancer. PURPOSE: Randomized clinical trial to study the effectiveness of bexarotene in preventing breast cancer in women who are at genetic risk of developing breast cancer.

Key facts

Study ID

NCT00055991

Run by

Baylor Breast Care Center

People needed

87

Starts

2001-09-01

Expected to finish

2006-09-01

Last updated by the study team

2013-02-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
• M.D. Anderson Cancer Center at University of Texas — Houston, Texas, United States
• Dan L. Duncan Cancer Center at Baylor College of Medicine — Houston, Texas, United States
• Cancer Therapy and Research Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.